Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Bullboard Posts
Comment by RetailRubeon Feb 13, 2010 7:55pm
372 Views
Post# 16783824

RE: RE: RE: Everybody pay attention.....

RE: RE: RE: Everybody pay attention.....Som, I can relate to how you feel.  I am a veteran of Northstar Healthcare (down 97% from its high to its low) and International Frontier Resources (down 98% from where I first bought it until I sold it).

On SDI, I assume the reason for the revised offer and the meeting delay is the first offer was going to fail.  I assume Management received enough proxy votes AGAINST that Management decided to crank up the number of units on offer so they could contact the funds that submitted "AGAINST" votes and offer them units at 40 cents if they change their vote to "FOR".  The press release does not mention who will get the bulk of the additional shares in the revised offer.  (I could be wrong.  Maybe they did find more friends waiting to buy in, so they opened it up again.)

That means there was no cash from the first offer because big shareholders (funds) thought it was too cheap, too much dilution, etc.  I was shocked that the second offer did not sweeten the price.  It's an attractive project, so 10-20 cents extra in the price would still leave lots of upside for MS.

I am a recent shareholder so I cannot vote.  I wait for veterans like yourself to make their decision.  But I come back to my original question:  If MS walks away, where do we get the cash?

PS:  Please tell me sometime how to do bold case.

Bullboard Posts